Hamit Kucuk

Dr. Hamit Kucuk

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SYSongul Baglan Yentur
Songul Baglan Yentur
SKSaliha Karatay
Saliha Karatay
DODeran Oskay
Deran Oskay
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN
HKHamit Kucuk
Hamit Kucuk
SHSeminur Haznedaroglu
Seminur Haznedaroglu
This study was designed to investigate the relationship between kinesiophobia and the level of physical activity, depression, disease activity, fatigue, pain, and quality of life in female patients with systemic lupus erythematosus (SLE). Seventy volunteer female patients were included in the study. Kinesiophobia, physical activity level, disease activity, fatigue, depression, pain, and quality of life were assessed using the Tampa Scale for Kinesiophobia (TSK), International Physical Activity Questionnaire- Short Form (IPAQ), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF) and Nottingham Health Profile (NHP), respectively. Two-thirds of the patients in the study had a high degree of kinesiophobia. Although there was a significant correlation between kinesiophobia and depression and some subscales of quality of life (sleep, social isolation, emotional reactions) (P < 0.05), no significant correlation with other parameters was found. As a result of this study, the majority of SLE patients included in the study were identified as having high levels of kinesiophobia. Patients’ fear and avoidance reaction from movement can be influenced by psychosocial factors. Treatments focusing on kinesiophobia of SLE patients could be beneficial in increasing the success of rehabilitation.

5 December 2016 in Renal Failure
Verified
Journal Article
Open access
HKHamit Kucuk
Hamit Kucuk
BGBerna Göker
Berna Göker
ÖVÖzkan Varan
Özkan Varan
BDBurak Dumludag
Burak Dumludag
ŞHŞeminur Haznedaroğlu
Şeminur Haznedaroğlu
YEYasemin Erten
Yasemin Erten
Introduction: Granulomatosis with polyangiitis (GPA) is a rare necrotizing vasculitis, which usually involves the upper and lower respiratory systems and kidneys and often have a relapsing course. Neutrophil/lymphocyte ratio (NLR) has been shown to be a useful marker predicting not only progressive disease, but also mortality in various inflammatory diseases. We aimed to investigate the roles of NLR in predicting the extend of clinical involvement and prognosis of patients with GPA. Materials and methods: Consecutive newly diagnosed GPA patients who had follow-up for at least 6 months between 2010 and 2016 at Gazi University Internal Medicine-Rheumatology clinic were retrospectively analyzed. Results: Fifty-three newly diagnosed GPA patients were studied. NLR was significantly higher in the GPA group compared with the control group (4.50 [min–max: 0.07–34.81] vs 1.77 [min–max: 1.04–2.90], respectively, p < .001). NLR significantly correlated with ESR and CRP levels (r = .40 and r = .48, respectively, p < .001 for both). Discussion: GPA is a vasculitis with a significant morbidity and mortality (REF). Renal involvement usually presents with crescentric glomerulonephritis, resulting in significant and permanent loss of renal functions and end-stage kidney disease. Higher NLR at baseline is associated with worse renal outcome. Our findings suggest that baseline NLR could have a predictive value for renal prognosis. We have also demonstrated a significant correlation between NLR and BVAS activity scores. Our data suggest that GPA patients with a significantly high NLR at baseline might need closer follow-up for persistent disease activity.

24 June 2023 in Rheumatology
Verified
Journal Article
Closed access
PDF file
BYBurcu Yagiz
Burcu Yagiz
NLNihal Lermi
Nihal Lermi
BCBelkis Nihan Coşkun
Belkis Nihan Coşkun
EDEdiz Dalkilic
Ediz Dalkilic
SKSedat Kiraz
Sedat Kiraz
YPYavuz Pehlivan
Yavuz Pehlivan
Objectives: The objectives of this study were to assess the clinical characteristics, predictive factors, and practical algorithms of paradoxical reactions (PRs), specifically paradoxical psoriasis (PP). Methods: The TReasure database is a web-based prospective observational cohort comprised of patients with RA and SpA from 17 centres around Turkey since 2017. A cohort study and a case–control study nestled within the cohort were identified. Results: In total, 2867 RA and 5316 SpA patients were evaluated. The first biologic agent was found to have caused PRs in 60% of the 136 patients (1.66%) who developed the PRs. The median time interval between the PRs and biological onset was 12 months (range 1–132 months, mean 21 months). The most common types of PP, constituting 92.6% of PRs, were pustular (60.3%) and palmoplantar (30.9%). Adalimumab (30.9%), infliximab (19%) and etanercept (17.4%) were the most common agents causing the PP. In the treatment of most PP patients (73.2%), switching biologic agents was favoured, with TNF inhibitor (TNFi) chosen in 46.03% and non-TNFi in 26.9% of cases. The three most frequently selected drugs were etanercept (24.6%), secukinumab (9.5%) and adalimumab (8.7%). Only 5.17% of patients who switched to another TNFi showed progression. The odds ratios (s) for SSZ, HCQ, and LEF use were significantly higher in RA controls than in PP patients (P = 0.033, OR = 0.15; P = 0.012, OR = 0.15; and P = 0.015, OR = 0.13, respectively). In the PP group with SpA, the number of smokers was significantly higher (P = 0.003, OR: 2.0, 95% CI: 1.05, 3.81). Conclusion: Contrary to expectations based on earlier research suggesting that paradoxical reactions develop with the class effect of biological agents, the response of patients who were shifted to another TNFi was favourable.

9 August 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
LALütfi Akyol
Lütfi Akyol
BTBahtiyar Toz
Bahtiyar Toz
ÖBÖzün Bayındır
Özün Bayındır
OZOrhan Zengin
Orhan Zengin
DCDöndüüsküdar Cansu
Döndüüsküdar Cansu
MSMehmet Sayarlıoğlu
Mehmet Sayarlıoğlu

27 December 2022 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
FSFulden Sari
Fulden Sari
SBSelin Bayram
Selin Bayram
GPGamze Gülsün Pala
Gamze Gülsün Pala
FÇFatma Çömçe
Fatma Çömçe
HKHamit Kucuk
Hamit Kucuk
DODeran Oskay
Deran Oskay
Background: The aim of research is to investigate the effectiveness of inspiratory muscle training (IMT) on exercise capacity, lower muscle strength, dyspnea, anxiety-depression, quality of life, physical activity and fatigue in individuals with respiratory effects involvement who have had COVID-19. Materials and Methods: Twenty-six patients were seperated to 2 groups as treatment group (TG) (breathing exercise, resistance training, IMT) and control group (CG) (breathing exercise, resistance training). All patients were evaluated at baseline and 6 weeks later in terms of exercise capacity, lower muscle strength, dyspnea, quality of life, fatigue, physical activity and anxiety-depression. Results: Significant difference was found in all parameters within the group after treatment. (p<0.05). TG was found superior to CG for increasing exercise capacity (p<0.05), lower muscle strength (p=0.001), anxiety-depression (p<0.05). Conclusions: IMT improves exercise capacity and lower muscle strength and decreases anxiety-depression in the patients.

3 August 2022 in European Journal of Rheumatology
Verified
Journal Article
Open access
DYDerya Yıldırım
Derya Yıldırım
RKRıza Can Kardaş
Rıza Can Kardaş
BÖBurcugul Özkızıltaş
Burcugul Özkızıltaş
IVİbRahim Vasi
İbRahim Vasi
HKHamit Kucuk
Hamit Kucuk
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN
Patients with familial Mediterranean fever and spondylitis often fail to respond to conventional and biologic therapies. Achieving remission in these patients usually requires conventional and biologic treatment combinations. Combination of biologic agents may be a promising option for patients with familial Mediterranean fever and spondylitis who have refractory disease. Until recently, limited evidence existed regarding the efficacy and safety of this treatment strategy. To address this, our report presented a case series of 4 patients with familial Mediterranean fever and spondylitis who were resistant to standard treatments and in whom remission is achieved only with dual biologic therapy. The authors also conducted a literature search for studies that reported dual biological therapy in inflammatory diseases. Cite this article as: Yıldırım D, Kardaş RC, Özkızıltaş B, et al. Dual biologic therapy in patients with familial mediterranean fever and spondyloarthritis: case-based review. Eur J Rheumatol 2023;10(1):29-33.